VACCELERATE Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment
Number of pages: 21Posted: 07 Apr 2022
You are currently viewing this paper
Downloads 22
Abstract
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the key role that vaccines play against infectious diseases. Although clinical trials were rapidly established during this pandemic, identifying suitable study subjects can be challenging. For this reason, the University Hospital Cologne established a volunteer registry for participation in clinical trials first in Germany, which has now been incorporated into the European VACCELERATE clinical trials network and grew to a European Volunteer Registry. As such, VACCELERATE’s Volunteer Registry aims to become a common entry point for potential volunteers in future clinical trials in Europe.
Methods: Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. The registry is open to both adults and children, complying with national legal consent requirements.
Results: As of January 2022, the questionnaire is available in 9 countries and 11 languages. Up to date, more than 35,000 volunteers have registered, mainly from Germany. Within the first year since its establishment, the VACCELERATE Volunteer Registry has matched 13,719 volunteers to clinical trials. The VACCELERATE Volunteer Registry will be launched in further European countries in the coming months.
Conclusion: The VACCELERATE Volunteer Registry is an active single-entry point for European residents interested in COVID-19 clinical trials participation in 9 countries. To date, more than 13,000 registered individuals have been connected to clinical trials in Germany alone. The registry is currently in the implementation phase in 6 additional countries.
Salmanton-Garcia, Jon and Stewart, Fiona A. and Heringer, Sarah and Koniordou, Markela and Álvarez-Barco, Elena and Argyropoulos, Christos D. and Themistocleous, Sophia and Valle-Simón, Paula and Spivak, Orly and Součková, Lenka and Merakou, Christina and Mendonça, Maria Amélia and Davis, Ruth Joanna and Azzini, Anna Maria and Askling, Helena H. and Vene, Sirkka and Van Damme, Pierre and Steinbach, Angela and Shiamakkides, George and Seidel, Danila and Olesen, Ole F. and Noula, Evgenia and Macken, Alan and Luís, Catarina and Leckler, Janina and Launay, Odile and Isitt, Catherine and Hellemans, Margot and Frías, Jesús and Carcas, Antonio J and Boustras, Georgios and Borobia, Alberto M and Barta, Imre and Albus, Kerstin and Akova, Murat and ochando, jordi and Cohen-Kandli, Miriam and Cox, Rebecaa and Husa, Petr and Jancoriene, Ligita and Mallon, Patrick and Marques, Laura and Mellinghoff, Sibylle and Nauclér, Pontus and Tacconelli, Evelina and Tóth, Krisztina and Zaoutis, Theoklis E. and Zeitlinger, Markus and Cornely, Oliver A. and Pana, Zoi-Dorothea and consortium, the VACCELERATE, VACCELERATE Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment. Available at SSRN: https://ssrn.com/abstract=4046771
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
1
PAPERS
1,612
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.